medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number 3

<< Back Next >>

Rev Mex Pediatr 2004; 71 (3)

Clinical effectiveness of two sedation schemes with ketamine in pediatrics dentistry

Soria-Espinosa LG, Juárez-López LA, Mayorga-Muñoz A
Full text How to cite this article

Language: Spanish
References: 23
Page: 116-122
PDF size: 73.29 Kb.


Key words:

Ketamine, midazolam, sedation.

ABSTRACT

Objective. The objective of this work was to evaluate the effectiveness and security of two schemes for deep sedation in pediatric patients: ketamine, droperidol, nalbufine and atropine (KDNA) versus ketamine, midazolam, atropine and oxidize nitrous (KMAN2O-O2). Material and methods. There were selected 30 children from 24 to 40 months old and negative conduct. They were randomly distributed into two groups, for each one of the regimens, that were administered by intramuscularly route. The sedation level was evaluated according to the Ramsay’s scale. The vital signs were continuously monitored. Results. All the patients reached level 6 according to the Ramsay’s scale. The induction and recovery time was smaller for the group that received KMAN2O-O2 (p < 0.05). There were observed differences in the vital signs behavior, the KMAN2O-O2 group showed greater stability (p > 0.05). Conclusions. Both KDNA and KMAN2O-O2 schemes showed to be effective for sedation in pediatric dentistry, without clinically significant changes in the vital signs. Nevertheless we considered that KMAN2O-O2combination is more recommendable for the oral rehabilitation in ambulatory procedures.


REFERENCES

  1. Henderson B, Triplett G, Gage W. Sedación con ansiolíticos ingeribles e intravenosos. En: Clínicas Odontológicas de Norteamérica. Farmacología. México: Interamericana 1994; 4: 587-27.

  2. Roberts G, Welbury R. Management of pain and anxiety. In: Pediatric Dentistry. New York: Ed. Oxford University Press; 1997: 412-75.

  3. Gelmon S, Macko D. Sedation. In: Castaldi C, Brass G. Dentistry for the adolescent. USA: Ed. Library of congress cataloging; 1980: 238-53.

  4. Costa F, Albajara V, De Nova G. Sedación en odontopediatría. Aspectos farmacológicos. Revista Europea de Odonto-Estomatología 1997; IX(4): 259-69.

  5. Juárez LA, Ramírez G, Sánchez R. Sedación y anestesia en odontopediatría. México: Facultad de Estudios Superiores Zaragoza; 2001.

  6. Dionne RA, Yagiela JA, Moore PA, Gonty A, Zuniga J, Beirne OR. Comparing efficacy and safety of four intravenous sedation regimens in dental outpatients. J Am Dent Assoc 2001; 132(6): 740-51.

  7. Ganzberg S, Pape R, Beck M. Remifentanil for use during conscious sedation in outpatient oral surgery. J Oral Maxillofac Surg 2002; 60: 244-250.

  8. Davila JM, Herman AE, Proskin HM, Vitale D. Comparison of the sedative effectiveness of two pharmacological regimens. J Dent Child 1994: 276-281.

  9. Malamed S. Sedación. Guía práctica. 3a edición, España: Mosby; 1996: 408-30.

  10. Lerch C, Park G. Sedation and analgesia. British Medical Bulletin 1999; 55(1): 76-95.

  11. Parker R, Rosemary A, Guigliano D, Parker M. Efficacy and safety of intravenous midazolam and ketamine as sedation for therapeutic and diagnostic procedures in children. Pediatr 1997; 99(3): 427-431.

  12. Kennedy RM, Porter FL, Jaffe DM. Comparison of fentanyl/midazolam with Ketamine/midazolam for pediatric orthopedic emergencies. Pediatrics 1998; 102: 956-963.

  13. Juárez LL, Curiel NC, Ramírez GG, Sánchez LR. Analgesia con óxido nitroso combinado con midazolam en pacientes odontopediátricos: Evaluación clínica. Práctica Odontológica 2001; 22(6): 24-30.

  14. Stephen W, McCann W, Larse P. The effects of nitrous oxide on behavior and physiological parameters during conscious sedation with a moderate dose of chloral hydrate and hydroxyzine. Pediatric Dent 1996; 18(1): 35-41.

  15. Shapira J, Holan G, Batzer E, Tal E, Fuks BA, Kupieztky A. The effectives of midazolam and hydroxyzyne as sedative agents for young pediatric dental patients. J Dent Child 1996; 6(3): 421-425.

  16. Templeton DA, Dembo J, Ferreti G, Dawahara LT, Pelphery AL. A comparative study of midazolam to meperidine/promethazine as an IM sedative technique for the pediatric dental patient. J Dent Child 1994; 5: 175-181.

  17. De la Teja E, Martínez Y. Sedación en odontopediatría, comparación del midazolam vía intranasal con el diazepam vía oral. Práctica Odontológica 1995; 16(12): 18-22.

  18. Aldrete JA. Anestesiología teórico-práctico. México: Editorial Salvat Mexicana; 1991: 125-6.

  19. Barash PG, Cullen BF, Stoelting RK. Anestesia Clínica. 3a Ed. México: McGraw-Hill Interamericana; 2000; 1: 148-56.

  20. Lienhart A. Anesthesie-reanimation. Encycl Med Chir (Elservier, Paris France) 1990: 36-279.

  21. Marx CM, Stein J, Tyler MK, Nieder, Shurin SB, Blumer JL. Ketamine-midazolam versus meperidine-midazolam for painful procedures in pediatric oncology patients. J Clinc Oncol 1997; 99: 427-31.

  22. Fernández C, Rey A, Medina A, Concha S, Menéndez M. Comparación de ketamina-midazolam con propofol-midazolam para sedación y analgesia en pediatría. Bol Pediatr 2000; 40: 19-23.

  23. Trapp LD. An evaluation of droperidol for preventing nausea and vomiting after deep intravenous sedation for ambulatory dental surgery. Anesth Prog 1999; 36: 9-12.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2004;71